IP Library › Granted Patent US 12,351,794
Granted Patent B2
US 12,351,794 · App. 17/847,653 · Granted Jul 8, 2025

Medium supplement for high-yield industrial culture of fastidious anaerobes and medium composition containing the same

Inventors: Jae-Gu Seo (Gimpo-si, KR); Do-Kyung Lee (Seoul, KR)
Assignee: ENTEROBIOME INC.
C12N1/20C12R2001/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,351,794
App. No.
17/847,653
Granted
Jul 8, 2025
Kind
B2
Abstract

A medium supplement for high-yield culture of anaerobes is disclosed. The medium supplement includes N-acetylhexosamine, L-aspartic acid, L-cysteine and cobalamin. A culture medium including the supplement and a culture method using the culture medium are also disclosed. It is possible to provide an innovative method which is capable of achieving high-concentration culture of anaerobes that are difficult to culture in high yield. The method is cost-effective, and in particular, is capable of culturing large amounts of fastidious aerobes suitable for use in food and pharmaceutical applications.

Claims (11)

1. A medium composition for culture of anaerobes, the medium composition comprising: plant peptone; yeast extract; potassium phosphate dibasic; as a carbon source, maltose and lactose; and as supplements, N-acetylhexosamine, an amino acid mixture of L-aspartic acid and L-cysteine, and cobalamin,

wherein the anaerobes are selected from the group consisting of Faecalibacterium prausnitzii, Anaerostipes caccae, Akkermansia muciniphila , and Bifidobacterium longum.

2. The medium composition of claim 1 , containing 20 g/L of plant peptone, 10 g/L of yeast extract, 2.5 g/L of potassium phosphate dibasic, 2.5 g/L of maltose, 2.5 g/L of lactose, 5 g/L of N-acetylhexosamine, 8 g/L of L-aspartic acid, 0.5 g/L of L-cysteine, and 0.0001 to 0.005 g/L of cobalamin.

3. The medium composition of claim 1 , wherein the plant peptone is selected from the group consisting of soy peptone, wheat peptone, cotton peptone, pea peptone, broadbean peptone, lupin peptone, and potato peptone.

4. The medium of claim 1 , wherein the anaerobes are Faecalibacterium prausnitzii or Akkermansia muciniphila.

5. A method for culturing anaerobes, the method comprising inoculating anaerobes into the medium composition of claim 1 and culturing the inoculated anaerobes under anaerobic conditions.

6. The method of claim 5 , wherein the culturing is performed under conditions of a pH of 6.6 to 7.0, a culture temperature of 35 to 39° C., an agitation speed of 40 to 50 rpm, a nitrogen saturation degree of 80 to 90%, a hydrogen saturation degree of 0 to 5%, and a carbon dioxide saturation degree of 5 to 20%.

7. The method of claim 5 , wherein the cultured anaerobes reach a cell density corresponding to a viable cell count of 10 10 CFU/mL or more as measured by a plate count method.

8. The method of claim 5 , wherein a nitrogen saturation degree is 80%, a hydrogen saturation degree is 0%, and a carbon dioxide saturation degree is 20%.

9. The method of claim 5 , wherein the anaerobes are Faecalibacterium prausnitzii or Akkermansia muciniphila.

10. A method for culturing anaerobes, the method comprising inoculating anaerobes into the medium composition of claim 2 and culturing the inoculated anaerobes under anaerobic conditions.

Priority Claims (1)
KR 10-2020-0150111 · Nov 11, 2020 · national
Continuity (2)
Continuation 17431212
Related Publication 20220325233A1 · Oct 13, 2022
References Cited (26)
US 10988509B2 · Belzer · 2021 [cited by applicant]
US 11377633B2 · Seo · 2022 [cited by examiner]
US 20180094233A1 · Belzer · 2018 [cited by examiner]
US 20200345055A1 · Frese · 2020 [cited by applicant]
CN 108699509A · 2018 [cited by applicant]
CN 110079474A · 2019 [cited by applicant]
KR 1020130021920A · 2013 [cited by applicant]
KR 1020150133646A · 2015 [cited by applicant]
KR 101809172B1 · 2017 [cited by applicant]
KR 1020180018524A · 2018 [cited by applicant]
KR 1020200041280A · 2020 [cited by applicant]
WO 2018106844A1 · 2018 [cited by applicant]
WO 2020079026A1 · 2020 [cited by applicant]
Derrien et al., “ [cited by applicant]
Stams et al., “Growth of Syntrophic Propionate-Oxidizing Bacteria with Fumarate in the Absence of Methanogenic Bacteria”, Applied and Environmental Microbiology, Apr. 1993, vol. 59, No. 4, pp. 1114-1119 (6 pages). [cited by applicant]
Extended European Search Report dated Jul. 18, 2022, issued in European Application No. 20922488.0. [cited by applicant]
Communication dated Jul. 11, 2022, issued in Indian Application No. 202227007748. [cited by applicant]
International Search Report of PCT/KR2020/019214 dated Aug. 4, 2021 [PCT/ISA/210]. [cited by applicant]
Written Opinion of PCT/KR2020/019214 dated Aug. 4, 2021 [PCT/ISA/237]. [cited by applicant]
Korean Intellectual Property Office, Office Action in Application No. 10-2020-0150111 dated Jan. 3, 2021. [cited by applicant]
Communication dated Jan. 21, 2022 by the United States Patent and Trademark Office in U.S. Appl. No. 17/431,212. [cited by applicant]
“Hexose”, https://en.wikipedia.org/wiki/Hexose (Year: 2022). [cited by applicant]
“N-Acetylhexosamine”, https://pubchem.ncbi.nlm.nih.gov/compound/N-Acetylhexosamine (Year: 2022). [cited by applicant]
Kevin D'HOE, et al. “Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community”, eLife, 2018, vol. 7, pp. 1-29 (29 pages). [cited by applicant]
“Oxoid peptone product (LP) Laboratory preparations and Biological Extracts”, Thermo Scientific, 2012 (5 pages). [cited by applicant]
Japanese Office Action dated Jun. 4, 2024, in Application No. 2023-122972. [cited by applicant]